[4261 CB (tetrazepam) in the treatment of cerebral palsy. Introduction to the study of the drug and of its action].
D000293:Adolescent; D001238:Asphyxia Neonatorum / Q000150:complications; D001264:Athetosis / Q000188:drug therapy; D001552:Benzazepines / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000150:complications; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D004660:Encephalitis / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D009069:Movement Disorders / Q000188:drug therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D012046:Rehabilitation
D001552:Benzazepines; D009125:Muscle Relaxants, Central
Le 4261 CB (tétrazépam) dans le traitement des infirmes moteurs cérébraux. Introduction à l'étude du produit et de son action.